Position in RXST
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$87,733
+$17,670 QoQ
Shares Held
18,202
+60.0% QoQ
Ownership
0.044%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#93
of 151 holders
Holding Since
Jun 2025
5 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in RXST Over Time
Shares Held
Position Value (USD)
Position in Medical Devices
Healthcare · as of Jun 30, 2026Brevan Howard Capital Management LP holds $46,922,231 across 36 Medical Devices names. RXST ranks #34 (0.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | STE |
STERIS plc
|
20,654 | $4,349,112 | |
| 2 | BIO |
Bio-Rad Laboratories, Inc.
|
13,718 | $4,027,741 | |
| 3 | UFPT |
Ufp Technologies Inc
|
13,400 | $3,552,742 | |
| 4 | EW |
Edwards Lifesciences Corp
|
34,889 | $3,156,058 | |
| 5 | TXG |
10x Genomics, Inc.
|
77,803 | $2,982,967 | |
| 6 | BSX |
Boston Scientific Corp
|
68,883 | $2,939,925 | |
| 7 | SYK |
Stryker Corp
|
9,013 | $2,837,652 | |
| 8 | IRTC |
iRhythm Holdings, Inc.
|
23,847 | $2,836,600 |
All Filings in RXST
Export CSV
5 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $87,733 | 18,202 | Shares | Defined | 2026-08-14 | |
| 2026-03-31 | $70,063 | 11,374 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $307,317 | 29,493 | Shares | Defined | 2026-02-17 | |
| 2025-09-30 | $194,327 | 21,616 | Shares | Defined | 2025-11-14 | |
| 2025-06-30 | $171,041 | 13,157 | Shares | Defined | 2025-08-14 | |
| No filing history on record for this holder in this stock. | ||||||